The Association between Helicobacter pylori Infection and Body Weight among Children
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: We performed to reveal the association between the Helicobacter pylori infection and body weight among children.Methods: Out retrospective study included patients who underwent the H. pylori immunoglobulin G testing at Konyang University Hospital between March 2011 and June 2014. These patients were classified as seropositive (28 boys, 27 girls; mean age: 9.89±3.28 years) or seronegative (55 boys, 54 girls; mean age: 9.84±3.02 years). Next, we com-pared various characteristics between the seropositive and negative groups, as well as between obese children (body weight ≥90th percentile) and non-obese children (body weight ＜90th percentile). Furthermore, we compared the change in body weight after 2 months of treatment with amoxicillin, clarithromycin and omeprazole among the 55 seropositive children (14 treated children and 41 non-treated children).Results: There were no differences in the weights and laboratory data for the 55 seropositive children and 109 sero-negative children (weight; 40.96±18.11 kg vs. 36.85±13.72 kg, respectively; p=0.14). And, there was no difference in the prevalence of H. pylori infection among the 29 obese and 135 non-obese children (p=0.581). However, after 2 months of eradication, the 14 treated patients exhibited a significant weight gain (＋0.91±0.52 kg), compared to the 41 non-treated patients (−0.29±1.16 kg, p=0.025).Conclusion: Our findings present that obesity was not associated with the H. pylori infection, although H. pylori erad-ication led to significant increase in body weight.
Abstract
Purpose: We performed to reveal the association between the Helicobacter pylori infection and body weight among children.Methods: Out retrospective study included patients who underwent the H. pylori immunoglobulin G testing at Konyang University Hospital between March 2011 and June 2014. These patients were classified as seropositive (28 boys, 27 girls; mean age: 9.89±3.28 years) or seronegative (55 boys, 54 girls; mean age: 9.84±3.02 years). Next, we com-pared various characteristics between the seropositive and negative groups, as well as between obese children (body weight ≥90th percentile) and non-obese children (body weight ＜90th percentile). Furthermore, we compared the change in body weight after 2 months of treatment with amoxicillin, clarithromycin and omeprazole among the 55 seropositive children (14 treated children and 41 non-treated children).Results: There were no differences in the weights and laboratory data for the 55 seropositive children and 109 sero-negative children (weight; 40.96±18.11 kg vs. 36.85±13.72 kg, respectively; p=0.14). And, there was no difference in the prevalence of H. pylori infection among the 29 obese and 135 non-obese children (p=0.581). However, after 2 months of eradication, the 14 treated patients exhibited a significant weight gain (＋0.91±0.52 kg), compared to the 41 non-treated patients (−0.29±1.16 kg, p=0.025).Conclusion: Our findings present that obesity was not associated with the H. pylori infection, although H. pylori erad-ication led to significant increase in body weight.
참고문헌 (30)
- Arslan D, "Helicobacter pylori infection in children with insulin dependent diabetes mellitus", J Pediatr Endocrinol Metab, 13, pp.553~556 (2000)
- Senturk O, "Prevalence and comparisons of five different diagnostic methods for Helicobacter pylori in diabetic patients", Endocr Res, 27, pp.179~189 (2001)
- Quatrini M, "Helicobacter pylori prevalence in patients with diabetes and its relationship to dyspeptic symptoms", J Clin Gastroenterol, 32, pp.215~217 (2001)
- Gulcelik NE, "Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy", J Endocrinol Invest, 28, pp.214~217 (2005)
- Chimienti G, "Helicobacter pylori is associated with modified lipid profile: impact on lipoprotein( a)", Clin Biochem, 36, pp.359~365 (2003)
- Laurila A, "Association of Helicobacter pylori infection with elevated serum lipids", Atherosclerosis, 142, pp.207~210 (1999)
- Hoffmeister A, "Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile", Arterioscler Thromb Vasc Biol, 21, pp.427~432 (2001)
- Jafarzadeh A, "Serum concentrations of Helicobacter pylori IgG and the virulence factor CagA in patients with ischaemic heart disease", East Mediterr Health J, 16, pp.1039~1044 (2010)
- Niccoli G, "Coronary atherosclerotic burden in patients with infection by CagA-positive strains of Helicobacter pylori", Coron Artery Dis, 21, pp.217~221 (2010)
- Grau AJ, "Helicobacter pylori infection as an independent risk factor for cerebral ischemia of atherothrombotic origin", J Neurol Sci, 186, pp.1~5 (2001)
- Diomedi M, "Cytotoxin-associated Gene-A-positive Helicobacter pylori strains infection increases the risk of recurrent atherosclerotic stroke", Helicobacter, 13, pp.525~531 (2008)
- Kopácová M, "European Society for Primary Care Gastroenterology. Body indices and basic vital signs in Helicobacter pylori positive and negative persons", Eur J Epidemiol, 22, pp.67~75 (2007)
- Arslan E, "The prevalence of Helicobacter pylori in obese subjects", Eur J Intern Med, 20, pp.695~697 (2009)
- Ioannou GN, "Is Helicobacter pylori seropositivity related to body mass index in the United States", Aliment Pharmacol Ther, 21, pp.765~772 (2005)
- Cho I, "Helicobacter pylori and overweight status in the United States: data from the Third National Health and Nutrition Examination Survey", Am J Epidemiol, 162, pp.579~584 (2005)
- Azuma T, "Eradication of Helicobacter pylori infection induces an increase in body mass index", Aliment Pharmacol Ther, 16(Suppl 2), pp.240~244 (2002)
- Furuta T, "Effect of Helicobacter pylori infection and its eradication on nutrition", Aliment Pharmacol Ther, 16, pp.799~806 (2002)
- Kamada T, "Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients", Dig Liver Dis, 37, pp.39~43 (2005)
- Rosenstock SJ, "Association of Helicobacter pylori infection with lifestyle, chronic disease, body-indices, and age at menarche in Danish adults", Scand J Public Health, 28, pp.32~40 (2000)
- Thjodleifsson B, "Infections and obesity: a multinational epidemiological study", Scand J Infect Dis, 40, pp.381~386 (2008)
- Azuma T, "Gastric leptin and Helicobacter pylori infection", Gut, 49, pp.324~329 (2001)
- Kamada T, "Development of obesity and hyperlipidemia after eradication of Helicobacter pylori", Nihon Rinsho, 63(Suppl 11), pp.536~538 (2005)
- Fujiwara Y, "Long-term effect of Helicobacter pylori eradication on quality of life, body mass index, and newly developed diseases in Japanese patients with peptic ulcer disease", Hepatogastroenterology, 49, pp.1298~1302 (2002)
- Loffeld RJ, "Helicobacter pylori, obesity and gastro- oesophageal reflux disease. Is there a relation? A personal view", Neth J Med, 63, pp.344~347 (2005)
- Akamizu T, "Translational research on the clinical applications of ghrelin", Endocr J, 53, pp.585~591 (2006)
- Williams DL, "Regulation of ghrelin in physiologic and pathophysiologic states", J Nutr, 135, pp.1320~1325 (2005)
- Chen CY, "Ghrelin gene products and the regulation of food intake and gut motility", Pharmacol Rev, 61, pp.430~481 (2009)
- Kawashima J, "Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis", J Gastroenterol, 44, pp.1046~1054 (2009)
- Gunji T, "Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population", Am J Gastroenterol, 103, pp.3005~3010 (2008)
- de Oliveira AM, "Evaluation of enzyme- linked immunosorbent assay for the diagnosis of Helicobacter pylori infection in children from different age groups with and without duodenal ulcer", J Pediatr Gastroenterol Nutr, 28, pp.157~161 (1999)